ReviewApplied microbiology and biotechnology2025
Recent fermentation developments for improved rhamnolipid production.
Review in Applied microbiology and biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Acetate as alternative carbon source for production of mono- and di-rhamnolipids in Pseudomonas putida KT2440.Microbial cell factories · 2026Article
- Cost-Effective rhamnolipids production from corn Bran and their application in essential oil extraction.World journal of microbiology & biotechnology · 2026Article
- A review of yeast-derived emulsifiers developed through microbial fermentation for the food sector.Frontiers in microbiology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Rhamnolipids (RL) are microbial amphiphilic molecules containing a hydrophilic rhamnose head and a hydrophobic fatty acid tail. RL are of interest to academia and industry due to their potential as a biosurfactant, being used to substitute petroleum-based surfactants in traditional applications or in novel bioremediation and biomedical applications. Currently, commercialization of RL is still in a nascent state, and improved RL production in terms of titers, yields, and productivities could benefit their techno-economic viability and market competitiveness. This review provides a detailed assessment of recent studies that have achieved higher RL production through improvements in microbial producers, media formulation, fermentation design, and operations. Key successes and areas for future work are identified and discussed in detail, as well as put into context with pilot-scale and techno-economic analysis of RL production from the wider literature. This review provides an updated perspective on the current status of RL production. The discussions and insights provided could potentially be used to improve future RL and biosurfactant commercialization efforts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.